Avecho Biotechnology
(ASX) AVE
Avecho Biotechnology Financials at a Glance
Market Cap
$29.39M
Revenue (TTM)
$2.37M
Net Income (TTM)
$6.20M
EPS (TTM)
$-0.00
P/E Ratio
-5.71
Dividend
$0.00
Beta (Volatility)
0.58 (Low)
Dividend
$0.00
Beta (Volatility)
0.58 (Low)
Price
$0.01
Volume
4,160,330
Open
$0.01
Price
$0.01
Volume
4,160,330
Open
$0.01
Previous Close
$0.01
Daily Range
$0.01 - $0.01
52-Week Range
$0.00 - $0.01
Dividend
$0.00
Beta (Volatility)
0.58 (Low)
Price
$0.01
Volume
4,160,330
Open
$0.01
Previous Close
$0.01
Daily Range
$0.01 - $0.01
52-Week Range
$0.00 - $0.01
AVE News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Avecho Biotechnology
Industry
Pharmaceuticals
Sector
Health CareCEO
Paul David Gavin, PhD
Website
www.avecho.com.auHeadquarters
Clayton, VIC 3168, AU
AVE Financials
Key Financial Metrics (TTM)
Gross Margin
61%
Operating Margin
-5%
Net Income Margin
-2%
Return on Equity
-183%
Return on Capital
-94%
Return on Assets
-43%
Earnings Yield
-17.51%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$29.39M
Shares Outstanding
3.67B
Volume
4.16M
Short Interest
0.00%
Avg. Volume
5.66M
Financials (TTM)
Gross Profit
$751.29K
Operating Income
$6.00M
EBITDA
$5.87M
Operating Cash Flow
$1.10M
Capital Expenditure
$0.00
Free Cash Flow
$1.10M
Cash & ST Invst.
$4.66M
Total Debt
$14.47K
Avecho Biotechnology Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$957.73K
+3432.5%
Gross Profit
$553.84K
+315.0%
Gross Margin
57.83%
N/A
Market Cap
$29.39M
N/A
Market Cap/Employee
$1.01M
N/A
Employees
29
N/A
Net Income
$1.74M
-33.0%
EBITDA
$4.60M
-139.2%
Quarterly Fundamentals
Net Cash
$4.65M
-12.8%
Accounts Receivable
$2.20M
+100.5%
Inventory
$8.07K
-91.7%
Long Term Debt
$0.00
-100.0%
Short Term Debt
$14.47K
-90.6%
Return on Assets
-43.32%
N/A
Return on Invested Capital
-93.86%
N/A
Free Cash Flow
$3.43M
-23.4%
Operating Cash Flow
$3.43M
-23.4%